Yoshimichi Shoji
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthesis and Structure-Activity Relationships of Novel Benzofuran Derivatives with Osteoblast Differentiation-Promoting Activity.
Journal: Chemical & pharmaceutical bulletin
Published: January 13, 2025
A Novel Series of Coumarin Derivatives That Exert Osteoblastogenic Effects in Mesenchymal Stem Cells and Osteogenic Effects in Ovariectomized Female Rats.
Journal: Chemical & pharmaceutical bulletin
Published: December 25, 2024
Synthesis and Evaluation of a Novel Series of Diphenylamine and Diphenylether Derivatives with Osteoblastogenic and Osteogenic Effects via CDK8 Inhibition.
Journal: Chemical & pharmaceutical bulletin
Published: October 06, 2024
Osteoblastgenic and Osteogenic Effects of KY-273 with CDK8/19 Inhibitory Activity in Bone Marrow Mesenchymal Stem Cells and Female Rats.
Journal: Biological & pharmaceutical bulletin
Published: March 20, 2024
Discovery of Novel Chromenopyridine Derivatives as Readthrough-Inducing Drugs.
Journal: Chemical & pharmaceutical bulletin
Published: December 03, 2023
Osteogenic Effects of KY-054, a Novel Coumarin Derivative on Femur Cortical Bone in Ovariectomized Female Rats.
Journal: Biological & pharmaceutical bulletin
Published: October 01, 2023
Synthesis and Evaluation of Novel Triaryl Derivatives with Readthrough-Inducing Activity.
Journal: Chemical & pharmaceutical bulletin
Published: September 04, 2023
A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: January 05, 2019
2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
Journal: Chemical & pharmaceutical bulletin
Published: December 04, 2018
Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
Journal: Chemical & pharmaceutical bulletin
Published: December 05, 2017
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
Journal: Journal of pharmacological sciences
Published: November 21, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026